Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin prophylaxis for surgical site infection after implant removal below the knee
NL-OMON54651Recruiting
- Sponsor
- ZonMw
- Start
- Dec 2019
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in surgical site infection (SSI) comparing Cefazolin prophylaxis with Placebo (2 arms). Primary endpoint: Proportion of patients with a surgical site infection within 90 days. Started Dec 2019; status: recruiting.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NL-OMON54651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54651.